SIGA Technologies, Inc.
420 Lexington Avenue
Suite 620
New York
New York
10170
United States
Tel: 212-672-9100
Fax: 212-697-3130
Website: http://www.siga.com/
Email: dkaufman@siga.com
174 articles about SIGA Technologies, Inc.
-
SIGA Technologies, Inc. to Present At the 2009 Noble Financial Fifth Annual Equity Conference
6/5/2009
-
SIGA Technologies, Inc. Submits Response to BARDA RFP
5/14/2009
-
SIGA Technologies, Inc. Produces FDA Registration Batches of ST-246(r) Drug Product
3/30/2009
-
SIGA Technologies, Inc. to Respond to Barda's Request for Proposal Seeking 1.7 Million Courses of Smallpox Antiviral
3/12/2009
-
SIGA Technologies, Inc. to Discuss Year-End 2008 Results of Operations On March 12, 2009
3/10/2009
-
SIGA Technologies, Inc. Clarifies European Regulatory Path for Lead Smallpox Anti-viral ST-246
1/13/2009
-
SIGA Technologies, Inc. Completes Manufacture of ST-246 Registration Batches
12/18/2008
-
SIGA Technologies, Inc. to Present ST-246 to the World Health Organization
11/12/2008
-
SIGA Technologies, Inc. Reports Operating Results for the Third Quarter of 2008
11/10/2008
-
SIGA Technologies, Inc. Applauds Efforts to Promote Private Sector Participation in Smallpox Biodefense
11/3/2008
-
SIGA Technologies, Inc. to Announce Third Quarter 2008 Results of Operations On November 10, 2008
10/31/2008
-
SIGA Technologies, Inc. Named to Deloitte Tri-State Area Technology Fast 50
10/23/2008
-
SIGA Technologies, Inc.' ST-246 Named 'Molecule of the Month' by Prous Science
10/16/2008
-
SIGA Technologies, Inc. to Present At The Homeland Security Investor Conference
10/15/2008
-
SIGA Technologies, Inc. To Participate In Committee Meeting For The Institute of Medicine
9/25/2008
-
SIGA Technologies, Inc. Receives Additional $20 Million From National Institutes of Health (NIH) for ST-246 Antiviral Therapeutic Development
9/19/2008
-
SIGA Technologies, Inc. to Attend the HHS Public Health Emergency Medical Countermeasures Enterprise Stakeholders Workshop 2008 and BARDA Industry Day
9/18/2008
-
National Institutes of Health (NIH) Funds SIGA Technologies, Inc. Lassa Antiviral Program
9/15/2008
-
National Institutes of Health (NIH) Funds SIGA Technologies, Inc. Dengue Antiviral Program
9/12/2008
-
SIGA Technologies, Inc. Awarded $55 Million by Federal Government to Develop Broader Applications for Its Lead Drug Candidate ST-246
9/3/2008